Hohimer Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-45,358
| Closed | -$3.8M | – | 250 |
|
|
2024
Q3 | $3.8M | Buy |
45,358
+47
| +0.1% | +$3.94K | 0.82% | 45 |
|
|
2024
Q2 | $3.11M | Sell |
45,311
-6,067
| -12% | -$416K | 0.72% | 55 |
|
|
2024
Q1 | $3.76M | Sell |
51,378
-400
| -0.8% | -$29.3K | 0.88% | 34 |
|
|
2023
Q4 | $4.19M | Buy |
51,778
+482
| +0.9% | +$39K | 1.06% | 24 |
|
|
2023
Q3 | $3.84M | Sell |
51,296
-1,289
| -2% | -$96.6K | 1.1% | 25 |
|
|
2023
Q2 | $4.05M | Sell |
52,585
-1,900
| -3% | -$146K | 1.12% | 18 |
|
|
2023
Q1 | $4.52M | Sell |
54,485
-1,475
| -3% | -$122K | 1.31% | 13 |
|
|
2022
Q4 | $4.8M | Sell |
55,960
-514
| -0.9% | -$44.1K | 1.53% | 13 |
|
|
2022
Q3 | $3.48M | Buy |
56,474
+796
| +1% | +$49.1K | 1.12% | 24 |
|
|
2022
Q2 | $3.44M | Sell |
55,678
-2,819
| -5% | -$174K | 1.02% | 29 |
|
|
2022
Q1 | $3.48M | Buy |
58,497
+3,939
| +7% | +$234K | 0.69% | 52 |
|
|
2021
Q4 | $3.96M | Sell |
54,558
-6,181
| -10% | -$449K | 0.83% | 36 |
|
|
2021
Q3 | $4.24M | Buy |
60,739
+581
| +1% | +$40.6K | 0.89% | 35 |
|
|
2021
Q2 | $4.14M | Buy |
60,158
+3,970
| +7% | +$273K | 0.85% | 39 |
|
|
2021
Q1 | $3.63M | Buy |
56,188
+4,702
| +9% | +$304K | 0.88% | 35 |
|
|
2020
Q4 | $3M | Buy |
51,486
+27,491
| +115% | +$1.6M | 0.8% | 35 |
|
|
2020
Q3 | $1.45M | Sell |
23,995
-743
| -3% | -$45K | 0.41% | 83 |
|
|
2020
Q2 | $1.9M | Sell |
24,738
-7,969
| -24% | -$613K | 0.66% | 48 |
|
|
2020
Q1 | $2.61M | Buy |
32,707
+4,103
| +14% | +$328K | 1.1% | 22 |
|
|
2019
Q4 | $1.86M | Buy |
+28,604
| New | +$1.86M | 0.65% | 56 |
|